12037 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Jul 20
13:32 UTC
|
PENG
Penguin Solutions
|
↓ Downgrade | Tom O'Malley not yet tracked | Equal Weight→ Underweight | $40.00 |
|
Jul 20
13:32 UTC
|
ALGM
Allegro MicroSystems
|
↓ Downgrade | Tom O'Malley not yet tracked | Overweight→ Equal Weight | $48.00 |
|
Jul 20
13:32 UTC
|
PAC
Grupo Aeroportuario Del Pacifico
|
↑ Upgrade | firm only | Neutral→ Buy | |
|
Jul 20
13:32 UTC
|
AKTX
Akari Therapeutics
|
↑ Upgrade | Jason McCarthy ★☆☆☆☆ #3027 | Hold→ Buy | $30.00 |
|
Jul 20
12:32 UTC
|
NEE
NextEra Energy
|
◎ Target | James Thalacker ★★★★☆ #549 | Outperform | $102.00→ $95.00-6.9% |
|
Jul 20
12:32 UTC
|
INTU
Intuit
|
◎ Target | James Friedman ★★☆☆☆ #2397 | Positive | $550.00→ $427.00-22.4% |
|
Jul 20
12:32 UTC
|
DT
Dynatrace
|
◎ Target | Ittai Kidron ★★★★☆ #605 | Outperform | $45.00→ $55.00+22.2% |
|
Jul 20
12:32 UTC
|
DDOG
Datadog
|
◎ Target | Ittai Kidron ★★★★☆ #605 | Outperform | $220.00→ $300.00+36.4% |
|
Jul 20
12:32 UTC
|
CLDX
Celldex Therapeutics
|
◎ Target | Yatin Suneja ★★★☆☆ #964 | Buy | $90.00→ $100.00+11.1% |
|
Jul 20
12:11 UTC
|
TSCO
Tractor Supply
|
◎ Target | Justin Kleber ★★☆☆☆ #2528 | Outperform | $50.00→ $38.00-24.0% |
|
Jul 20
12:11 UTC
|
TRVI
Trevi Therapeutics
|
◎ Target | Brandon Folkes ★★☆☆☆ #2535 | Buy | $21.00→ $24.00+14.3% |
|
Jul 20
12:11 UTC
|
TRV
Travelers Companies
|
◎ Target | Joshua Shanker ★★★★☆ #627 | Underperform | $283.00→ $307.00+8.5% |
|
Jul 20
12:11 UTC
|
TFC
Truist Financial
|
◎ Target | David George ★★★★☆ #478 | Neutral | $55.00→ $56.00+1.8% |
|
Jul 20
12:11 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Ami Fadia ★★★☆☆ #1352 | Buy | $235.00→ $236.00+0.4% |
|
Jul 20
12:11 UTC
|
RCUS
Arcus Biosciences
|
◎ Target | Emily Bodnar ★★☆☆☆ #2679 | Buy | $32.00→ $45.00+40.6% |
|
Jul 20
12:11 UTC
|
PBAM
Private Bancorp of America
|
◎ Target | Matthew Clark ★★★★☆ #366 | Overweight | $88.00→ $96.00+9.1% |
|
Jul 20
12:11 UTC
|
NTST
NETSTREIT
|
◎ Target | Eric Borden ★★★★☆ #655 | Outperform | $24.00→ $25.00+4.2% |
|
Jul 20
12:11 UTC
|
NMFC
New Mountain Finance
|
◎ Target | Paul Johnson ★★★☆☆ #1648 | Market Perform | $9.00→ $8.00-11.1% |
|
Jul 20
12:11 UTC
|
MRX
Marex Group plc Ordinary Shares
|
◎ Target | Daniel Fannon ★★★☆☆ #1642 | Buy | $57.00→ $80.00+40.4% |
|
Jul 20
12:11 UTC
|
KKR
KKR & Co. Inc.
|
◎ Target | Vikram Gandhi ★★★★☆ #449 | Buy | $118.00→ $121.00+2.5% |
|
Jul 20
12:11 UTC
|
JAZZ
Jazz Pharmaceuticals
|
◎ Target | Ami Fadia ★★★☆☆ #1352 | Buy | $255.00→ $282.00+10.6% |
|
Jul 20
12:11 UTC
|
INDB
Independent Bank
|
◎ Target | David Konrad ★★★★★ #28 | Outperform | $99.00→ $96.00-3.0% |
|
Jul 20
12:11 UTC
|
IMRX
Immuneering
|
◎ Target | Ami Fadia ★★★☆☆ #1352 | Buy | $11.00→ $18.00+63.6% |
|
Jul 20
12:11 UTC
|
FVR
FrontView REIT
|
◎ Target | Eric Borden ★★★★☆ #655 | Outperform | $21.00→ $24.00+14.3% |
|
Jul 20
12:11 UTC
|
FITB
Fifth Third Bancorp
|
◎ Target | Christopher McGratty ★★★★★ #131 | Market Perform | $58.00→ $60.00+3.4% |
|
Jul 20
12:11 UTC
|
EAT
Brinker International
|
◎ Target | Andrew M. Charles not yet tracked | Buy | $170.00→ $210.00+23.5% |
|
Jul 20
12:11 UTC
|
DUK
Duke Energy
|
◎ Target | James Thalacker ★★★★☆ #549 | Outperform | $138.00→ $134.00-2.9% |
|
Jul 20
12:11 UTC
|
DIS
Walt Disney
|
◎ Target | John Hodulik ★★☆☆☆ #2650 | Buy | $138.00→ $133.00-3.6% |
|
Jul 20
12:11 UTC
|
CSL
Carlisle Companies
|
◎ Target | Timothy Wojs ★★★☆☆ #1570 | Outperform | $425.00→ $405.00-4.7% |
|
Jul 20
12:11 UTC
|
CMS
CMS Energy
|
◎ Target | James Thalacker ★★★★☆ #549 | Outperform | $81.00→ $86.00+6.2% |
|
Jul 20
12:11 UTC
|
CBSH
Commerce Bancshares
|
◎ Target | David Konrad ★★★★★ #28 | Market Perform | $60.00→ $62.00+3.3% |
|
Jul 20
12:11 UTC
|
AMLX
Amylyx Pharmaceuticals
|
◎ Target | Graig Suvannavejh ★★☆☆☆ #2687 | Outperform | $21.00→ $24.00+14.3% |
|
Jul 20
12:11 UTC
|
SNEX
StoneX Group
|
↓ Downgrade | Daniel Fannon ★★★☆☆ #1642 | Buy→ Hold | $123.00→ $112.00-8.9% |
|
Jul 20
12:11 UTC
|
SCHW
Charles Schwab
|
↓ Downgrade | Brennan Hawken ★★★★☆ #416 | Outperform→ Market Perform | $105.00 |
|
Jul 20
12:11 UTC
|
PENG
Penguin Solutions
|
↓ Downgrade | Tom O'Malley not yet tracked | Overweight→ Underweight | |
|
Jul 20
12:11 UTC
|
MNST
Monster Beverage
|
↓ Downgrade | Steve Powers not yet tracked | Buy→ Hold | $94.00→ $98.00+4.3% |
|
Jul 20
12:11 UTC
|
CRL
Charles River Laboratories International
|
↓ Downgrade | Michael Luo not yet tracked | Outperform→ Hold | $219.00 |
|
Jul 20
12:11 UTC
|
YETI
YETI
|
↑ Upgrade | Brooke Roach ★★★☆☆ #1427 | Neutral→ Buy | $46.00→ $63.00+37.0% |
|
Jul 20
12:11 UTC
|
USB
U.S. Bancorp
|
↑ Upgrade | Vivek Juneja ★★★★☆ #407 | Underweight→ Neutral | $65.00→ $67.50+3.8% |
|
Jul 20
12:11 UTC
|
URBN
Urban Outfitters
|
↑ Upgrade | Brooke Roach ★★★☆☆ #1427 | Neutral→ Buy | $76.00→ $93.00+22.4% |
|
Jul 20
12:11 UTC
|
HOG
Harley-Davidson
|
↑ Upgrade | Brandon Rolle ★☆☆☆☆ #2754 | Hold→ Buy | $32.00 |
|
Jul 20
12:11 UTC
|
FRVO
Fervo Energy
|
↑ Upgrade | Julien Dumoulin-Smith not yet tracked | Hold→ Buy | $41.00→ $34.00-17.1% |
|
Jul 20
11:10 UTC
|
SNEX
StoneX Group
|
↓ Downgrade | Daniel Fannon ★★★☆☆ #1642 | Hold | |
|
Jul 20
11:10 UTC
|
YETI
YETI
|
↑ Upgrade | firm only | Neutral→ Buy | $63.00 |
|
Jul 20
11:10 UTC
|
URBN
Urban Outfitters
|
↑ Upgrade | firm only | Neutral→ Buy | $93.00 |
|
Jul 20
11:10 UTC
|
HOG
Harley-Davidson
|
↑ Upgrade | firm only | Hold→ Buy | |
|
Jul 20
11:10 UTC
|
FRVO
Fervo Energy
|
↑ Upgrade | Julien Dumoulin-Smith not yet tracked | Hold→ Buy | |
|
Jul 20
10:10 UTC
|
VALT
Valt Technology Services
|
◎ Target | firm only | Buy | GBX 7,100→ GBX 7,500+5.6% |
|
Jul 20
10:10 UTC
|
FGP
FirstGroup
|
◎ Target | firm only | Buy | GBX 240→ GBX 255+6.2% |
|
Jul 20
10:10 UTC
|
CCC
Computacenter
|
◎ Target | firm only | Buy | GBX 3,450→ GBX 5,300+53.6% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.